Each of these cannabis stocks has a lower forward P/E ratio than the benchmark S&P 500.
News & Analysis: The Supreme Cannabis Company
Marijuana stocks don't get much cheaper than this.
Despite incredible long-term growth potential, these marijuana companies are trading like value stocks.
Which stock wins in a matchup between a top ancillary provider to the cannabis industry and a small Canadian cannabis producer?
This small cannabis company is largely flying under the radar, but investors would do well to remember its name.
Each and every one of these marijuana stocks has a lower forward P/E ratio than the S&P 500, but is growing substantially faster.
Supreme Cannabis recorded some impressive numbers in Q4, and it's expecting even better ones in the next fiscal year.
Despite being one of the largest cannabis stocks by market cap, a number of considerably smaller peers may outsell Cronos next year.
With up to 196% upside, should these cannabis stocks be in your portfolio?
Derivative cannabis products will soon hit licensed Canadian dispensaries.